Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Macrofarm is an Italian biotechnology company and a spin-off from the University of Calabria that specializes in the research, development, and production of functional ingredients and advanced delivery systems. The company focuses on 'smart materials' such as hydrogels, nanoparticles, and functional polymers designed for the pharmaceutical, nutraceutical, and cosmetic industries. Their core expertise lies in the controlled release of active ingredients and the enhancement of bioavailability for various bioactive compounds. Macrofarm provides R&D services, formulation development, and specialized manufacturing for health and beauty applications. The company's technology is utilized to improve the stability and efficacy of antioxidants, vitamins, and other therapeutic agents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Macrofarm.